3SBio : PRELIMINARY RESULTS OF SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2020

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or on reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1530)

(Convertible Bonds Code: 40285)

PRELIMINARY RESULTS OF SUNSHINE GUOJIAN PHARMACEUTICAL

(SHANGHAI) CO., LTD.

FOR THE YEAR ENDED 31 DECEMBER 2020

The board of directors (the "Board") of 3SBio Inc. (the "Company") is pleased to announce that Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.* ( 三生國健藥業 ( 上海 ) 股份有限公司 ) ("Sunshine Guojian"), a subsidiary of the Company whose shares are listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange (stock code: 688336), published its preliminary results (the "Preliminary Results") for the year ended ended 31 December 2020 on 26 February 2021.

The Board would like to draw the attention of the shareholders and investors of the Company to the following unaudited key financial information and indicators of Sunshine Guojian for the year ended 31 December 2020, as extracted from the Preliminary Results:

For the current
reporting	corresponding	Increase/
Items	period	period last year	decrease (%)
Total operating income	65,500.58	117,739.18	-44.37%
Operating profit	-18,880.27	25,983.42	-172.66%
Total profit	-26,412.62	22,923.14	-215.22%
Net profit attributable to owners
of the parent	-20,025.86	22,929.52	-187.34%
Net profit attributable to owners of the
parent after non-recurring profit or loss	-19,530.15	29,278.39	-166.70%
Basic earnings per share (RMB)	-0.35	0.43	-180.40%
Weighted average return on net assets	-5.54%	7.22%	-12.76%
End of the	Beginning of
current	the current
reporting	reporting	Increase/
period	period	decrease (%)
Total assets	497,086.11	332,000.04	49.72%
Equity attributable to owners of the parent	452,033.74	286,801.19	57.61%
Share capital	61,621.14	55,459.03	11.11%
Net assets per share attributable to owners
of the parent (RMB)	7.34	5.17	41.97%

Unit: RMB ten thousand For the

Note: The full text of the Preliminary Results is published on the information disclosure page of the website of the Shanghai

Stock Exchange (http://www.sse.com.cn/assortment/stock/list/info/announcement/index.shtml?productId=688336).

Shareholders and investors are reminded that the financial information above was prepared in accordance with PRC accounting standards and is an extract of the unaudited financial statements prepared by Sunshine Guojian. In case of any discrepancy between the Chinese version and the English version, the Chinese version shall prevail.

By order of the Board

3SBio Inc.

Dr. LOU Jing

Chairman

Shenyang, the PRC

26 February 2021

As at the date of this announcement, the directors of the Company are Dr. LOU Jing and Ms. SU Dongmei as executive directors; Mr. HUANG Bin and Mr. TANG Ke as non-executive directors; and Mr. PU Tianruo, Mr. David Ross PARKINSON and Dr. WONG Lap Yan as independent non-executive directors.